• 1. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 2. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 3. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 4. Aluminium alkyl and aryloxide complexes of pyrazine and bipyridines: synthesis and structure?
  Doug Ogrin,Laura H. van Poppel,Simon G. Bott,Andrew R. Barron Dalton Trans., 2004, 3689-3694
• 5. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Comprehensive Analysis of 2-(butan-2-yl)aminoacetic acid hydrochloride (CAS No. 6939-21-5): Properties, Applications, and Industry Insights

In the realm of specialty chemicals, 2-(butan-2-yl)aminoacetic acid hydrochloride (CAS No. 6939-21-5) stands out as a versatile compound with significant applications in pharmaceuticals, agrochemicals, and biochemical research. This hydrochloride salt, derived from the amino acid glycine, is gaining attention due to its unique structural properties and functional versatility. Researchers and industry professionals are increasingly exploring its potential in drug synthesis, peptide modification, and as a chiral building block in asymmetric synthesis.

The molecular structure of 2-(butan-2-yl)aminoacetic acid hydrochloride features a secondary butyl group attached to the amino nitrogen, which enhances its lipophilicity compared to simpler amino acid derivatives. This property makes it particularly valuable in the design of bioactive molecules with improved membrane permeability. Recent studies highlight its role in optimizing pharmacokinetic profiles of lead compounds, addressing one of the most pressing challenges in modern drug discovery – oral bioavailability enhancement.

From a synthetic chemistry perspective, the CAS 6939-21-5 compound offers several advantages. Its crystalline nature ensures high purity, while the hydrochloride salt form provides excellent solubility in aqueous systems – a critical factor for formulation development. Analytical data from HPLC and NMR studies confirm its stability under standard storage conditions, making it a reliable reagent for laboratory and industrial applications. The compound's melting point (typically 180-185°C with decomposition) and spectral characteristics are well-documented in technical literature.

In the context of current industry trends, 2-(butan-2-yl)aminoacetic acid hydrochloride aligns with the growing demand for custom amino acid derivatives in medicinal chemistry. Pharmaceutical companies are particularly interested in its potential as a prodrug moiety, where the butylamino group can serve as a biodegradable carrier for active pharmaceutical ingredients. This application addresses the increasing need for targeted drug delivery systems, a hot topic in precision medicine research.

The compound's role in peptide engineering deserves special mention. As researchers develop more complex peptide therapeutics, modified amino acids like 2-(butan-2-yl)aminoacetic acid provide crucial tools for introducing structural diversity. Its incorporation into peptide chains can enhance metabolic stability without significantly altering the overall conformation – a key consideration in the design of peptide-based drugs for diabetes, oncology, and cardiovascular diseases.

Quality control specifications for CAS 6939-21-5 typically include stringent limits on residual solvents and heavy metals, reflecting its pharmaceutical-grade status. Manufacturers employ advanced purification techniques such as recrystallization from appropriate solvent systems to achieve the required purity levels (>98% by HPLC). These quality standards ensure batch-to-batch consistency, which is essential for regulatory compliance in cGMP environments.

From an environmental standpoint, 2-(butan-2-yl)aminoacetic acid hydrochloride demonstrates favorable biodegradability characteristics in standard OECD tests. This ecological profile makes it an attractive option for companies implementing green chemistry principles in their synthetic workflows. The compound's manufacturing process has been optimized to minimize waste generation, aligning with the pharmaceutical industry's commitment to process sustainability.

Looking ahead, the market for specialized amino acid derivatives like 2-(butan-2-yl)aminoacetic acid hydrochloride is projected to grow significantly. This growth is driven by expanding applications in bioconjugation chemistry and the development of novel small molecule therapeutics. As research continues to uncover new uses for this versatile building block, its importance in both academic and industrial settings is likely to increase substantially in the coming years.

• 82017-41-2((Cycloheptylamino)acetic Acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)